Literature DB >> 25446256

Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells.

Lawrence C Blume1, Khalil Eldeeb1, Caroline E Bass1, Dana E Selley2, Allyn C Howlett1.   

Abstract

CB1 cannabinoid receptors (CB1R) are one of the most abundantly expressed G protein coupled receptors (GPCR) in the CNS and regulate diverse neuronal functions. The identification of GPCR interacting proteins has provided additional insight into the fine-tuning and regulation of numerous GPCRs. The cannabinoid receptor interacting protein 1a (CRIP1a) binds to the distal carboxy terminus of CB1R, and has been shown to alter CB1R-mediated neuronal function [1]. The mechanisms by which CRIP1a regulates CB1R activity have not yet been identified; therefore the focus of this investigation is to examine the cellular effects of CRIP1a on CB1R signaling using neuronal N18TG2 cells stably transfected with CRIP1a over-expressing and CRIP1a knockdown constructs. Modulation of endogenous CRIP1a expression did not alter total levels of CB1R, ERK, or forskolin-activated adenylyl cyclase activity. When compared to WT cells, CRIP1a over-expression reduced basal phosphoERK levels, whereas depletion of CRIP1a augmented basal phosphoERK levels. Stimulation of phosphoERK by the CB1R agonists WIN55212-2, CP55940 or methanandamide was unaltered in CRIP1a over-expressing clones compared with WT. However, CRIP1a knockdown clones exhibited enhanced ERK phosphorylation efficacy in response to CP55940. In addition, CRIP1a knockdown clones displayed a leftward shift in CP55940-mediated inhibition of forskolin-stimulated cAMP accumulation. CB1R-mediated Gi3 and Go activation by CP99540 was attenuated by CRIP1a over-expression, but robustly enhanced in cells depleted of CRIP1a. Conversely, CP55940-mediated Gi1 and Gi2 activation was significant enhanced in cells over-expressing CRIP1a, but not in cells deficient of CRIP1a. These studies suggest a mechanism by which endogenous levels of CRIP1a modulate CB1R-mediated signal transduction by facilitating a Gi/o protein subtype preference for Gi1 and Gi2, accompanied by an overall suppression of G-protein-mediated signaling in neuronal cells.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CB(1) receptor; CRIP1a; ERK1/2; Endocannabinoid; G protein; cAMP

Mesh:

Substances:

Year:  2014        PMID: 25446256      PMCID: PMC4332989          DOI: 10.1016/j.cellsig.2014.11.006

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  35 in total

1.  CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains.

Authors:  S Mukhopadhyay; A C Howlett
Journal:  Eur J Biochem       Date:  2001-02

Review 2.  CB(1) cannabinoid receptor-G protein association: a possible mechanism for differential signaling.

Authors:  Somnath Mukhopadhyay; Joong-Youn Shim; Abdel-Azim Assi; Derek Norford; Allyn C Howlett
Journal:  Chem Phys Lipids       Date:  2002-12-31       Impact factor: 3.329

3.  Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

Authors:  M Herkenham; A B Lynn; B R de Costa; E K Richfield
Journal:  Brain Res       Date:  1991-05-03       Impact factor: 3.252

4.  Modulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression system.

Authors:  M Rinaldi-Carmona; A Le Duigou; D Oustric; F Barth; M Bouaboula; P Carayon; P Casellas; G Le Fur
Journal:  J Pharmacol Exp Ther       Date:  1998-12       Impact factor: 4.030

5.  Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.

Authors:  A C Howlett; J M Qualy; L L Khachatrian
Journal:  Mol Pharmacol       Date:  1986-03       Impact factor: 4.436

6.  Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.

Authors:  L J Sim; R E Hampson; S A Deadwyler; S R Childers
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

7.  Inverse agonist properties of N-(piperidin-1-yl)-5-(4-chlorophenyl)-1-(2, 4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide HCl (SR141716A) and 1-(2-chlorophenyl)-4-cyano-5-(4-methoxyphenyl)-1H-pyrazole-3-carboxyl ic acid phenylamide (CP-272871) for the CB(1) cannabinoid receptor.

Authors:  J P Meschler; D M Kraichely; G H Wilken; A C Howlett
Journal:  Biochem Pharmacol       Date:  2000-11-01       Impact factor: 5.858

8.  Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.

Authors:  A C Howlett; R M Fleming
Journal:  Mol Pharmacol       Date:  1984-11       Impact factor: 4.436

9.  Constitutive endocytic cycle of the CB1 cannabinoid receptor.

Authors:  Christophe Leterrier; Damien Bonnard; Damien Carrel; Jean Rossier; Zsolt Lenkei
Journal:  J Biol Chem       Date:  2004-06-21       Impact factor: 5.157

10.  Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.

Authors:  Tiziana Bisogno; Fiona Howell; Gareth Williams; Alberto Minassi; Maria Grazia Cascio; Alessia Ligresti; Isabel Matias; Aniello Schiano-Moriello; Praveen Paul; Emma-Jane Williams; Uma Gangadharan; Carl Hobbs; Vincenzo Di Marzo; Patrick Doherty
Journal:  J Cell Biol       Date:  2003-11-10       Impact factor: 10.539

View more
  16 in total

1.  Molecular Interaction between Distal C-Terminal Domain of the CB1 Cannabinoid Receptor and Cannabinoid Receptor Interacting Proteins (CRIP1a/CRIP1b).

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Chem Inf Model       Date:  2019-12-10       Impact factor: 4.956

2.  Mouse Neuroblastoma CB1 Cannabinoid Receptor-Stimulated [35S]GTPɣS Binding: Total and Antibody-Targeted Gα Protein-Specific Scintillation Proximity Assays.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  Methods Enzymol       Date:  2017-07-19       Impact factor: 1.600

3.  CB1 cannabinoid receptor-mediated increases in cyclic AMP accumulation are correlated with reduced Gi/o function.

Authors:  Khalil Eldeeb; Sandra Leone-Kabler; Allyn C Howlett
Journal:  J Basic Clin Physiol Pharmacol       Date:  2016-05-01

4.  In silico interaction analysis of cannabinoid receptor interacting protein 1b (CRIP1b) - CB1 cannabinoid receptor.

Authors:  Pratishtha Singh; Anjali Ganjiwale; Allyn C Howlett; Sudha M Cowsik
Journal:  J Mol Graph Model       Date:  2017-09-06       Impact factor: 2.518

5.  Cannabinoid Receptor Interacting Protein 1a Competition with β-Arrestin for CB1 Receptor Binding Sites.

Authors:  Lawrence C Blume; Theresa Patten; Khalil Eldeeb; Sandra Leone-Kabler; Alexander A Ilyasov; Bradley M Keegan; Jeremy E O'Neal; Caroline E Bass; Roy R Hantgan; W Todd Lowther; Dana E Selley; A Llyn C Howlett
Journal:  Mol Pharmacol       Date:  2016-11-28       Impact factor: 4.436

6.  RGS2 modulates the activity and internalization of dopamine D2 receptors in neuroblastoma N2A cells.

Authors:  Deborah J Luessen; Tyler P Hinshaw; Haiguo Sun; Allyn C Howlett; Glen Marrs; Brian A McCool; Rong Chen
Journal:  Neuropharmacology       Date:  2016-08-12       Impact factor: 5.250

7.  A rare genomic duplication in 2p14 underlies autosomal dominant hearing loss DFNA58.

Authors:  Karina Lezirovitz; Gleiciele A Vieira-Silva; Ana C Batissoco; Débora Levy; Joao P Kitajima; Alix Trouillet; Ellen Ouyang; Navid Zebarjadi; Juliana Sampaio-Silva; Vinicius Pedroso-Campos; Larissa R Nascimento; Cindy Y Sonoda; Vinícius M Borges; Laura G Vasconcelos; Roberto M O Beck; Signe S Grasel; Daniel J Jagger; Nicolas Grillet; Ricardo F Bento; Regina C Mingroni-Netto; Jeanne Oiticica
Journal:  Hum Mol Genet       Date:  2020-06-03       Impact factor: 6.150

8.  CB1 cannabinoid receptor-phosphorylated fourth intracellular loop structure-function relationships.

Authors:  Khalil Eldeeb; Anjali D Ganjiwale; Indu R Chandrashekaran; Lea W Padgett; Jason Burgess; Allyn C Howlett; Sudha M Cowsik
Journal:  Pept Sci (Hoboken)       Date:  2018-12-14

9.  Cannabinoid receptor interacting protein suppresses agonist-driven CB1 receptor internalization and regulates receptor replenishment in an agonist-biased manner.

Authors:  Lawrence C Blume; Sandra Leone-Kabler; Deborah J Luessen; Glen S Marrs; Erica Lyons; Caroline E Bass; Rong Chen; Dana E Selley; Allyn C Howlett
Journal:  J Neurochem       Date:  2016-09-26       Impact factor: 5.372

10.  Cannabinoid receptor-interacting protein 1a modulates CB1 receptor signaling and regulation.

Authors:  Tricia H Smith; Lawrence C Blume; Alex Straiker; Jordan O Cox; Bethany G David; Julie R Secor McVoy; Katherine W Sayers; Justin L Poklis; Rehab A Abdullah; Michaela Egertová; Ching-Kang Chen; Ken Mackie; Maurice R Elphick; Allyn C Howlett; Dana E Selley
Journal:  Mol Pharmacol       Date:  2015-02-05       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.